• Source: Medetomidine/vatinoxan

Medetomidine/vatinoxan, sold under the brand name Zenalpha, is a veterinary fixed dose combination medication used as a sedative and analgesic for dogs. It contains medetomidine, an alpha2-adrenoceptor agonist, as the hydrochloride; and vatinoxan, an alpha2-adrenoceptor antagonist, as the hydrochloride.
It was approved for veterinary use in the United States in May 2022, and in Canada in May 2023.




References

Kata Kunci Pencarian:

• Medetomidine/vatinoxan
• Atipamezole
• Alpha-2 blocker
• Xylazine
• Beta blocker
• Alpha-2 adrenergic receptor
• Salbutamol
• Epinephrine (medication)
• Antianginal
• Atenolol